The study to see the effect of Marmatherapy in lowback pain which occurs due to lumbar disc prolapse.
Phase 2
- Conditions
- Health Condition 1: M498- Spondylopathy in diseases classified elsewhere
- Registration Number
- CTRI/2024/07/070564
- Lead Sponsor
- DR MADHURI BHANDARE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Clinically diagnosed patients of lumbar disc prolapse and confirmed by x-ray (lumbosacral spine AP & Lat view) and MRI spine
2.Age group between 25yrs to 45 yrs
3.Lumbar disc prolapse of L4-L5
4.Chronic Lumbar disc prolapse i.e. more than 3 weeks
5.Male and female
6.Controlled DM &HTN patients
Exclusion Criteria
1.Pregnant female
2.Paraplegia due to lumbar disc prolapse
3.Vertebral fracture, Potts spine
4.Kyphosis & Scoliosis
5.Rheumatoid arthritis, Spondyolisthesis, Ankylosing spondylitis patients
6.Benign & malignant tumors of vertebral column & spine
7.Metastatic deposits at spine
8.Metabolic disorders like Osteoporosis & Osteomalacia
9.HIV Positive & HbsAg positive patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Reduction in pain of lower back and legs. <br/ ><br>2.Improvement in movements of lower back and legs.Timepoint: 10 Days
- Secondary Outcome Measures
Name Time Method 1. Forming of standard operating procedures of Marma Therapy in individuals with lumbar disc prolapse. <br/ ><br> <br/ ><br>2. Studying the effect of Marma Therapy on selected Marma points in individuals with lumbar disc prolapse.Timepoint: 36 Months